Mylan sues generic rival Teva over ‘sophisticated scheme’ to block Copaxone copycats

Mylan sues generic rival Teva over ‘sophisticated scheme’ to block Copaxone copycats
fkansteiner
Thu, 07/01/2021 – 10:28